PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29595858-0	2018	Calycosin directly improves perivascular adipose tissue dysfunction by upregulating the adiponectin/AMPK/eNOS pathway in obese mice.	7,3'-dihydroxy-4'-methoxyisoflavone	0-9	adiponectin, C1Q and collagen domain containing	Mus musculus	88-99	
29595858-10	2018	This beneficial effect of calycosin was eliminated by treatments of blocking adiponectin, AMPK or eNOS.	7,3'-dihydroxy-4'-methoxyisoflavone	26-35	adiponectin, C1Q and collagen domain containing	Mus musculus	77-88	
29595858-12	2018	Treatment of obese mice with calycosin significantly increased adiponectin levels, activated AMPK and eNOS phosphorylation and reduced superoxide production and TNF-alpha levels in PVAT.	7,3'-dihydroxy-4'-methoxyisoflavone	29-38	adiponectin, C1Q and collagen domain containing	Mus musculus	63-74	
29595858-13	2018	Our results indicated that calycosin restored PVAT induced anti-contractile activity and affected PVAT function through the adiponectin/AMPK/eNOS pathway in obese mice.	7,3'-dihydroxy-4'-methoxyisoflavone	27-36	adiponectin, C1Q and collagen domain containing	Mus musculus	124-135	
28699662-8	2018	RESULTS: Calycosin effectively decreased the levels of ALT and AST, increased the levels of adiponectin and insulin.	7,3'-dihydroxy-4'-methoxyisoflavone	9-18	adiponectin, C1Q and collagen domain containing	Mus musculus	92-103